Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


10.04.2017

1 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
1 Am J Psychiatry
1 BMC Neurol
4 Brain
1 Dement Geriatr Cogn Disord
16 J Alzheimers Dis
1 J Neural Transm (Vienna)
1 J Neurol
1 Nat Rev Neurol
3 Neurobiol Aging
1 Neurochem Res
2 Neurology
1 Neuroscience
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. MORENO DJ, Pino S, Rios A, Lopera F, et al
    Genetic Ancestry and Susceptibility to Late-Onset Alzheimer's Disease (LOAD) in the Admixed Colombian Population.
    Alzheimer Dis Assoc Disord. 2017 Mar 31. doi: 10.1097/WAD.0000000000000195.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  2. RITCHIE K, Carriere I, Su L, O'Brien JT, et al
    The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study.
    Alzheimers Dement. 2017 Mar 29. pii: S1552-5260(17)30093.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  3. LAVRETSKY H
    Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer's Disease and Psychosis or Agitation.
    Am J Psychiatry. 2017;174:307-308.
    PubMed     Text format    


    BMC Neurol

  4. ABUSHOUK AI, Elmaraezy A, Aglan A, Salama R, et al
    Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials.
    BMC Neurol. 2017;17:66.
    PubMed     Text format     Abstract available


    Brain

  5. HARDY J, De Strooper B
    Alzheimer's disease: where next for anti-amyloid therapies?
    Brain. 2017;140:853-855.
    PubMed     Text format    

  6. ROBERTS BR, Lind M, Wagen AZ, Rembach A, et al
    Biochemically-defined pools of amyloid-beta in sporadic Alzheimer's disease: correlation with amyloid PET.
    Brain. 2017 Mar 5. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. COULTHARD E, Knight M
    Refining Alzheimer's disease diagnosis with MRI.
    Brain. 2017;140:524-526.
    PubMed     Text format    

  8. CARAVAGGIO F, Graff-Guerrero A
    Is antipsychotic sensitivity in Alzheimer's disease secondary to abnormal blood-brain barrier integrity?
    Brain. 2017;140:865-867.
    PubMed     Text format    


    Dement Geriatr Cogn Disord

  9. MATIAS-GUIU JA, Valles-Salgado M, Rognoni T, Hamre-Gil F, et al
    Comparative Diagnostic Accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for Screening of Alzheimer Disease.
    Dement Geriatr Cogn Disord. 2017;43.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  10. LOPEZ-FONT I, Boix CP, Zetterberg H, Blennow K, et al
    Alterations in the Balance of Amyloid-beta Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161275.
    PubMed     Text format     Abstract available

  11. CRAFT S, Claxton A, Baker LD, Hanson AJ, et al
    Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161256.
    PubMed     Text format     Abstract available

  12. ROBB C, Udeh-Momoh C, Wagenpfeil S, Schope J, et al
    Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161162.
    PubMed     Text format     Abstract available

  13. JIANG C, Li G, Huang P, Liu Z, et al
    The Gut Microbiota and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161141.
    PubMed     Text format     Abstract available

  14. BRUEGGEN K, Kasper E, Ochmann S, Pfaff H, et al
    Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-160771.
    PubMed     Text format     Abstract available

  15. DOREY E, Bamji-Mirza M, Najem D, Li Y, et al
    Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-beta-Induced Inflammatory Response in vivo and in vitro.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-160133.
    PubMed     Text format     Abstract available

  16. JIANG S, Bhaskar K
    Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161123.
    PubMed     Text format     Abstract available

  17. WILLIAMS SM, Schulz P, Rosenberry TL, Caselli RJ, et al
    Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161116.
    PubMed     Text format     Abstract available

  18. OCHMANN S, Dyrba M, Grothe MJ, Kasper E, et al
    Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer's Disease? An Interventional Study.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-160773.
    PubMed     Text format     Abstract available

  19. BOHLKEN J, Jacob L, Kostev K
    Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-170091.
    PubMed     Text format     Abstract available

  20. NGUYEN MF, Bonnefoy M, Adrait A, Gueugnon M, et al
    Efficacy of Hearing Aids on the Cognitive Status of Patients with Alzheimer's Disease and Hearing Loss: A Multicenter Controlled Randomized Trial.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-160793.
    PubMed     Text format     Abstract available

  21. GARCIA A, Mathur S, Kalaw MC, McAvoy E, et al
    Quantitative 3D Telomeric Imaging of Buccal Cells Reveals Alzheimer's Disease-Specific Signatures.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161169.
    PubMed     Text format     Abstract available

  22. KEHOE PG, Hibbs E, Palmer LE, Miners JS, et al
    Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-beta and Tau Pathology.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161265.
    PubMed     Text format     Abstract available

  23. GARCIA B, Martin C, Olivia GS, Muniz-Alonso B, et al
    Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161298.
    PubMed     Text format     Abstract available

  24. XIE B, Liu Z, Liu W, Jiang L, et al
    DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-170007.
    PubMed     Text format     Abstract available

  25. ALONSO R, Pisa D, Aguado B, Carrasco L, et al
    Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-170058.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  26. THIERRY M, Marty S, Boluda S, Duyckaerts C, et al
    Alzheimer's senile plaque as shown by microcryodissection, a new technique for dissociating tissue structures.
    J Neural Transm (Vienna). 2017 Apr 6. doi: 10.1007/s00702-017-1718.
    PubMed     Text format     Abstract available


    J Neurol

  27. MASCALCHI M, Bessi V, Ginestroni A, Toschi N, et al
    Low MT ratio in hippocampus of amnestic MCI patients who will progress to AD.
    J Neurol. 2016;263:1024-6.
    PubMed     Text format    


    Nat Rev Neurol

  28. RIDLER C
    Alzheimer disease: Inhibition of IRE1 signalling reduces AD pathology.
    Nat Rev Neurol. 2017 Apr 7. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    


    Neurobiol Aging

  29. VIANA JN, Vickers JC, Cook MJ, Gilbert F, et al
    Currents of memory: recent progress, translational challenges, and ethical considerations in fornix deep brain stimulation trials for Alzheimer's disease.
    Neurobiol Aging. 2017 Mar 11. pii: S0197-4580(17)30072.
    PubMed     Text format     Abstract available

  30. ZHENG JY, Sun J, Ji CM, Shen L, et al
    Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-beta/Smad2/STAT3 signaling.
    Neurobiol Aging. 2017 Mar 11. pii: S0197-4580(17)30073.
    PubMed     Text format     Abstract available

  31. PEREZ SE, Nadeem M, He B, Miguel JC, et al
    Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease.
    Neurobiol Aging. 2017 Mar 9. pii: S0197-4580(17)30056.
    PubMed     Text format     Abstract available


    Neurochem Res

  32. ZHANG ZX, Zhao RP, Wang DS, Li YB, et al
    Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Abeta Production and Tau Hyperphosphorylation of the Hippocampus.
    Neurochem Res. 2016;41:3074-3082.
    PubMed     Text format     Abstract available


    Neurology

  33. PETERSEN RC, Thomas RG, Aisen PS, Mohs RC, et al
    Randomized controlled trials in mild cognitive impairment: Sources of variability.
    Neurology. 2017 Apr 5. pii: 10.1212/WNL.0000000000003907.
    PubMed     Text format     Abstract available

  34. RELKIN NR, Thomas RG, Rissman RA, Brewer JB, et al
    A phase 3 trial of IV immunoglobulin for Alzheimer disease.
    Neurology. 2017 Apr 5. pii: 10.1212/WNL.0000000000003904.
    PubMed     Text format     Abstract available


    Neuroscience

  35. FUHRER TE, Palpagama TH, Waldvogel HJ, Synek BJ, et al
    Impaired expression of GABA transporters in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.
    Neuroscience. 2017 Apr 3. pii: S0306-4522(17)30207.
    PubMed     Text format     Abstract available


    PLoS One

  36. TU MC, Lo CP, Huang CF, Hsu YH, et al
    Effectiveness of diffusion tensor imaging in differentiating early-stage subcortical ischemic vascular disease, Alzheimer's disease and normal ageing.
    PLoS One. 2017;12:e0175143.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: